A foundation of well-being.

Dr. Howard J. Fullman brings over four decades of clinical excellence and healthcare leadership as a board-certified gastroenterologist and internal medicine specialist. A Northwestern University medical school graduate, he completed his internal medicine residency and chief residency at UCSF and his gastroenterology fellowship at UCLA, earning triple fellowship honors from the American Gastroenterological Association, American College of Gastroenterology, and American College of Physicians. Dr. Fullman's operational expertise was forged during 34 years at Kaiser Permanente, where he served as a Partner attending physician and held multiple leadership roles including Board of Directors member and 16 years as Area Medical Director & Chief of Staff for the West Los Angeles Medical Center. His strategic advisory work spans healthcare organizations, investment banks, private equity, and venture capital—currently as Senior Advisor at Atoms Venture Capital (formerly Senior Operating Advisor at Atlantic Street Capital), where he guides emerging medtech investments and portfolio strategy. As Adjunct Professor of Healthcare Systems Engineering at Loyola Marymount University, he combines frontline medical insight with executive leadership to advise healthcare companies on clinical validation, operational scaling, and value creation.

A Clinical Associate Professor of Pediatrics at Stanford University, Dr. Mony translates clinical insights into sustainable solutions that work in resource-constrained environments—the true test of innovation. Her fellowships in three prestigious societies—Pediatric Infectious Diseases Society (FPIDS), Infectious Diseases Society of America (FIDSA), and Society for Healthcare Epidemiology of America (FSHEA)—reflect peer-recognized excellence and active contributions to national guidelines, thought leadership, and workforce development. Leading infectious diseases and epidemiology in a safety-net system means solving the hardest problems first—complex patient populations, limited resources, health inequities—and building solutions that are both clinically excellent and operationally sustainable. Her dual focus on pediatric and adult care provides a comprehensive view of infection prevention across the lifespan, while her commitment to embedding sustainability into clinical operations ensures interventions that last beyond implementation. Dr. Mony brings the trifecta to Beacon’s advisory board: deep clinical credibility, national thought leadership, and real-world implementation experience that bridges academic rigor with frontline pragmatism.

Dr. Robert J. Citronberg brings over three decades of frontline expertise in infectious diseases to his work in clinical safety. Educated at the University of Pennsylvania and the University of Connecticut School of Medicine, he completed his infectious disease fellowship at Rush University Medical Center. He has actively practiced in the Chicago area since 1994 and currently serves as the Executive Medical Director of Infectious Diseases and Infection Prevention for Advocate Health across Illinois and Wisconsin. His distinguished career includes elected fellowships with the American College of Physicians, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America.

Lew Radonovich is a Contributing Scholar at the Johns Hopkins Center for Health Security. He joined the Center after retiring from his position at the Centers for Disease Control and Prevention as the Deputy Director of the Respiratory Health Division in the National Institute for Occupational Safety and Health (NIOSH). Dr. Radonovich has approximately 30 years of clinical, research, and administrative experience focused primarily on respiratory health. In the Respiratory Health Division at NIOSH, he helped lead efforts to reduce the burden and impact of work-related respiratory health conditions utilizing interdisciplinary research and service teams that investigated occupational hazards, including airborne dusts, disinfecting agents, and aerosol-generating procedures. He also served at the National Personal Protective Technology Laboratory at NIOSH as a Senior Physician Scientist and Chief of Research, leading laboratory and clinical studies of respiratory protective devices and other personal protective equipment. One of his primary interests at NIOSH was translation of medical science to practice. Additionally, he worked at Blueprint Biosecurity as a Senior Advisor providing guidance about clinical science. Previously, he was the Director of the National Center for Occupational Health and Infection Control in the Veterans Health Administration where he oversaw scientific research, operational guidance, and practice recommendations at the intersection of occupational safety and airborne infectious disease transmission. Principal areas of study included effectiveness of respiratory protective devices, implementation of engineering infection controls, and stockpiling of personal protective equipment for epidemics and pandemics. Dr. Radonovich is a physician scientist with a background in internal medicine, clinical pharmacology, and clinical investigation. He was co-principal investigator of the Respiratory Protection Effectiveness Clinical Trial (ResPECT), a multi-site, cluster randomized clinical trial comparing the effectiveness of disposable respirators to surgical masks to protect healthcare workers from transmission of influenza virus and other respiratory viruses. He co-led Better Respiratory Equipment using Advanced Technologies for Healthcare Employees (Project BREATHE), a public-private partnership between U.S. federal agencies and U.S.-based respirator manufacturers. In addition to his research and clinical activities, Dr. Radonovich has served in a wide range of governmental leadership roles during public health emergencies, including the COVID-19 pandemic and the H1N1 influenza pandemic. He has numerous peer-reviewed publications, has spoken frequently and scientific meetings, and has previously held academic appointments at the University of Florida, the University of Pittsburgh, and Johns Hopkins University.

Margit K. Chapman brings over three decades of healthcare leadership combining frontline clinical expertise with executive technology strategy and organizational transformation. A registered nurse with a Bachelor of Science in Nursing from San Jose State University, Margit began her career in medical/surgical, oncology, and cardiology clinical practice at Stanford University Medical Center, El Camino Hospital, and Orlando Regional Medical Center, where she served as Associate Director for Education and Head Nurse. Transitioning to healthcare technology and consulting, Margit has held senior executive positions at leading healthcare organizations including Senior Manager at Ernst & Young Healthcare Consulting, Senior Vice President at iKNOWMED Systems (now McKesson/US Oncology), Executive Vice President at iMEDICA (now eMDs Aprima), Senior Clinician at HealthLink (IBM division), Director of Performance Transformation at Catholic Healthcare West (now Dignity Health), Vice President of Clinical Services at Dearborn Advisors, and Director of Professional Consulting Services at NextGen. Currently, she serves as Executive Director of Chapman Health Solutions, LLC, advising healthcare technology firms on market launch, clinical implementation, and strategic change management. Margit founded and chairs the HIMSS NorCal Clinical Advisory Council, bringing physician and clinician perspectives to healthcare technology strategy. As a Healthcare Angel Investor and Advisor with HIP Fund, she provides strategic guidance to early-stage digital health ventures, recognized for delivering valuable insights to healthcare innovation companies.

Cris Daugbjerg serves as Managing Director for iTD-Americas at TouchPoint Medical, leading sales, marketing, product management, and engineering operations to deliver medical device mounting solutions across the Americas. With over 25 years in the medical device industry, Cris has built a distinguished track record developing best-in-class products that enhance patient care and optimize clinical workflows. A Caltech-trained mechanical engineer with business management education from UC Berkeley, Cris spent his first 12 years engineering innovative healthcare products before transitioning to general management. At GCX Corporation, he led the company's evolution from a small machine shop to a global leader in medical mounting solutions, ultimately serving as Vice President of Development and Sales. His leadership produced breakthrough innovations including the industry-first Patient Engagement Table and championed the company's ISO 13485 medical device certification. As an independent consultant, he has advised healthcare businesses including UV disinfection technology startups, and currently serves as a Healthcare Investor and Advisor with HIP Fund, guiding early-stage medical technology ventures.

Ben is a scientist and engineer who specializes in early stage biotechnology research and development. He received his BS in applied physics from Emory University, and a PhD in biomedical engineering from UNC Chapel Hill and NC State University. He has over a decade of experience developing and validating novel test methods within the medical device and pharmaceutical industries as both an employee and consultant. Prior to joining the team at Beacon, he was the Senior Director of Test Method Development and Analytics at XCMR, Inc., where he focused on developing novel methods to assess the performance of UVC devices for respiratory protection and surgical site infection prevention.